A case of chronic eosinophilic pneumonia in a patient treated with dupilumab

The increasing knowledge on inflammatory pathways has driven the development of targeted biological therapies for severe refractory asthma. Among the recently developed biologics, the fully human monoclonal antibody dupilumab is an interesting therapeutic option, given its ability to inhibit the bio...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ther Clin Risk Manag
Главные авторы: Menzella, Francesco, Montanari, Gloria, Patricelli, Giulia, Cavazza, Alberto, Galeone, Carla, Ruggiero, Patrizia, Bagnasco, Diego, Facciolongo, Nicola
Формат: Artigo
Язык:Inglês
Опубликовано: Dove 2019
Предметы:
Case Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6636310/
https://ncbi.nlm.nih.gov/pubmed/31371974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S207402
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы